Matthew Charles McMurdo
CIK 1943108 · last filed 2024-10-01
Matthew Charles McMurdo is a corporate insider who has filed 6 SEC Form 4 insider transactions across 3 companies since 2023. The most recent filing, for MINM, was dated Oct 1, 2024.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
6
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FiEE, Inc. (MINM) Delisted | Director | 184,364 | $3.61 | $665.6K | $0 | 2 | 2024-10-01 |
| OPGEN INC (OPGN) Delisted | Director | 100,000 | $24.75 | $2.48M | $0 | 1 | 2024-04-12 |
| TITAN PHARMACEUTICALS INC (TTNP) Delisted | Director | 66,250 | $4.61 | $305.4K | $0 | 3 | 2023-10-26 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-01 | FiEE, Inc. (MINM) Delisted | Grant (A) | +159,364 | $0 | EDGAR |
| 2024-04-12 | OPGEN INC (OPGN) Delisted | Grant (A) | +100,000 | $0 | EDGAR |
| 2024-01-24 | FiEE, Inc. (MINM) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2023-10-26 | TITAN PHARMACEUTICALS INC (TTNP) Delisted | Grant (A) | +16,250 | $0 | EDGAR |
| 2023-07-31 | TITAN PHARMACEUTICALS INC (TTNP) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2023-07-28 | TITAN PHARMACEUTICALS INC (TTNP) Delisted | Grant (A) | +50,000 | $0 | EDGAR |